High Level of Glutathione-S-Transferase π Expression in Mantle Cell Lymphomas

Clinical Cancer Research

Volumn 10, Issue 9, 2004, Pages 3029-3034

  Bennaceur Griscelli, Annelise ^a   Bosq, Jacques ^a   Koscielny, Serge ^a   Lefrère, François ^b   Turhan, Ali ^a   Brousse, Nicole ^b   Hermine, Olivier ^b   Ribrag, Vincent ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; CYCLIN D1; GENE PRODUCT; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CARCINOGENESIS; CCND1 GENE; CHROMOSOME 11Q; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; ENZYME ACTIVITY; FEMALE; FOLLICULAR LYMPHOMA; GENE; GENE AMPLIFICATION; GENE FUNCTION; GENE LOCUS; GENE OVEREXPRESSION; GST GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 2442526494     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0554     Document Type: Article

References (39)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
2. Barista I, Romaguera JE, Cabanillas F. Mantle-cell lymphoma. Lancet 2001;2:141-8.
3. Ketterer N, Salles G, Espinouse D, et al. Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle-cell lymphoma. Ann Oncol 1997;8:701-4.
4. Stewart DA, Vose JM, Weisenburger DD, et al. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle-cell lymphoma. Ann Oncol 1995;6:263-6.
5. Decaudin D, Brousse N, Brice P, et al. Efficacy of autologous stem cell transplantation in mantle-cell lymphoma: a 3 year follow-up study. Bone Marrow Transplant 2000;25:251-6.
6. Khouri IF, Romaguera J, Kantarjian H, et al. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol 1998;16:3803-19.
7. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994;54:4313-20.
8. Cowan KH, Batist G, Tulpule A, Shinha BK, Myers CE. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc Natl Acad Sci USA 1986;83:928-32.
9. Robson CN, Lewis AD, Wolf CR, et al. Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione-S-transferase activity. Cancer Res 1987;47:6022-7.
10. Teicher BA, Holden SA, Kelley MJ, et al. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res 1987;47:388-93.
11. McGown AT, Fox BW. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother Pharmacol 1986;17:223-6.
12. Schisselbauer JC, Silber R, Papadopoulos E, et al. Characterization of glutathion-S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res 1990;50:3562-8.
13. Ciaccio PJ, Tew KD, LaCreta FP. Enzymatic conjugation of chlorambucil with glutathione is catalyzed by human glutathione-S-transferase and inhibition by etacrynic acid. Biochem Pharmacol. 1991; 42:1504-7.
14. Dirven HA, Dictus EL, Broeders NL, Van Hommen B, Van Bladeren PJ. The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating drug thiotepa. Cancer Res 1995;55:1701-6.
15. Ban N, Takahashi Y, Takayama T, et al. Transfection of glutathione S-transferase (GST) π antisense complementary DNA increases the sensitivity of a colon cancer cell line to Adriamycin, cisplatin, melphalan, and etoposide. Cancer Res 1996;56:3577-82.
16. Shiga H, Heath EI, Rasmussen AA, et al. Prognostic value of p53, glutathione S-transferase-π, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res 1999;5:4097-104.
17. Bai F, Nakanishi Y, Kawasaki M, et al. Immunohistochemical expression of glutathione S-transferase-π can predict chemotherapy response in patients with non small cell lung carcinoma. Cancer (Phila) 1996;52:967-77.
18. Tidefelt U, Elmhorn-Rosenborg A, Paul C, et al. Expression of glutathione transferase π as a predictor for treatment results at different stage of acute nonlymphoblastic leukemia. Cancer Res 1992;52:3281-5.
19. Ketterer B, Taylor J, Meyer D, et al. Some functions of glutathione transferases. In: Tew KD, Pickett CB, Mantle TJ, Mannervik B, Hayes JD, editors. Structure and function of glutathione transferases. Boca Raton, Florida: CRC press; 1993. p. 15-27.
20. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999;17:1244-53.
21. Mauvieux L, Canioni D, Hermine O, et al. Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle-cell lymphoma. Leukemia (Baltimore) 1998;12:78-85.
22. M'kacher R, Farace F, Bennaceur-Griscelli AL, et al. Blastioid mantle cell lymphoma: evidence for non-random cytogenetic abnormalities additional to t(11;14) and generation of a mouse model. Cancer Genet Cytogenet 2003;143:32-8.
23. Louie DC, Offit K, Jaslow R, et al. p53 overexpression as a marker of poor prognosis in mantle cell lymphoma with t(11;14)(q13;q32). Blood 1995;86:2892-9.
24. Hernandez L, Fest T, Caziora M, et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996;87:3351-9.
25. Kramer MH, Hermans J, Wijburg E, et al. Clinical significance of bc12 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. J Clin Oncol 1996;14:2131-8.
26. Hermine O, Haioun C, Lepage E, et al. Prognostic significance of bcl2-protein expression in aggressive non-Hodgkin's lymphomas. Blood 1996;87:265-72.
27. Lenoir G, Preud'homme J, Bernheim A, Berger R. Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature (Lond) 1982;98:474-6.
28. Berger R, Bernheim A. Cytogenetic studies in Burkitt's lymphoma leukemia. Cancer Genet Cytogenet 1982;7:231-4.
29. Vandenberghe Y, Tee L, Rogiers V, Yeoh G. Transcriptional and post-transcriptional-dependent regulation of glutathione S-transferase expression in rat hepatocytes as a function of culture conditions. FEBS Lett 1992;313:155-9.
30. Morrow CS, Chiu J, Cowan KH. Posttranscriptional control of glutathione S-transferase π gene expression in human breast cancer cells. J Biol Chem 1992;25:10544-50.
31. Moffat GJ, McLaren AW, Wolf CR. Transcriptional and posttranscriptional mechanisms can regulate cell-specific expression of the human π-class glutathione S-transferase gene. Biochem J 1997;15:91-5.
32. Jhaveri MS, Stephens TE, Morrow CS. Role of posttranscriptional processes in the regulation of glutathione S-transferase P1 gene expression in the human breast cancer. Biochem Biophys Res Commun 1997;28:729-34.
33. Ribrag V, Carpiuc I, Cebotaru C, et al. Prognostic value of GST-π in diffuse large B cell lymphoma. Leukemia (Baltimore) 2003;17: 972-7.
34. Yin Z, Ivanov VN, Habelhah H, Tew K, Ronai Z. Glutathione S-transferase π elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res 2000;60:4053-7.
35. Wang T, Arifoglu P, Ronai Z, Tew KD. Glutathione S-transferase P1-1 inhibits c-Jun N-terminal kinase signaling through interaction with the C terminus. J Biol Chem 2001;276:20999-1003.
36. Tang G, Minemoto Y, Dibling B, et al. Inhibition of JNK through NF-κB target genes. Nature (Lond) 2001;414:313-7.
37. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med 2002;346:1937-47.
38. Lefrère F, Delmer A, Belanger C, et al. Sequential chemotherapy associating CHOP and DHAP regimens is highly active to induce complete response in mantle cell lymphoma: a prospective study. Leukemia (Baltimore) 2002;16:587-93.
39. Grant S. Ara-C: cellular and molecular pharmacology. Adv Cancer Res 1998;197-233.